Harjeet SinghInstructor, Department of Pediatrics at UT MD Anderson Cancer Center, USA
Dr. Singh is an Instructor at The University of Texas MD Anderson Cancer Center, specializing in development and application of novel immunotherapeutic modalities. Dr. Singh received his PhD in Biochemistry, and trained in the labs of Drs. Ravi Bhatia and Laurence Cooper investigating the biology of hematologic malignancies and creating genetically modified T-cells to treat them. He has more than 10 years of experience in generating CARs and evaluating efficacy at a single cell level using biomarker analysis. His work has helped launch more than 10 investigator-initiated clinical trials evaluating both natural killer (NK) and T-cells.